We suppose the higher mRNA and protein levels of IDO in certain tumor microenvironments might function as a good prognostic factor in RCC, and the elevated PTEN expression might also be a good marker in most tumor cases. This evidence concerns the gene IDO1 and renal cell carcinoma.